home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Comprehensive Overview of FDA Regulatory Compliance for Drug and Biotech Products

 
  May 03, 2012  
     
 
Center for Professional Innovation & Education (CfPIE), Berlin, Germany
Oct. 11 & 12, 2012


This two-day course is designed to give participants of all levels a strong foundation in the fundamentals of FDA regulatory compliance for drugs and biotech products.  Additionally, this course will detail how to meet compliance objectives in a cost-contained manner.   Upon completion of the course attendees will understand the guidelines, philosophy and practical approach to FDA compliance.  Participants will have a firm grasp of the seven key strategies to cost-effective compliance, including the use of outsourced assistance, audits, simultaneous submissions, Quality by Design (QbD), use of operational definitions, reliance on electronic submissions, and prioritization of guidelines.  All attendees will receive ample resources for reference.
 
 
Organized by: Center for Professional Innovation & Education
Invited Speakers: Contact info@cfpie.com for a list of course instructors
 
Deadline for Abstracts: n/a
 
Registration: http://www.cfpie.com/showitem.aspx?productid=019&source=hummolgen
E-mail: info@cfpie.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.